2022
DOI: 10.1111/jpc.16202
|View full text |Cite
|
Sign up to set email alerts
|

Hope in the uncertainties and certainty for parents of children with rare neurological disorders: Part 2 (of 3): Certainty

Abstract: This is the second of a three‐part series that explores different aspects of uncertainty, certainty and hope in the context of providing clinical care for children with rare and life‐limiting neurological disorders. When caring for families impacted by an overwhelming complex disorder in a child, complicated by threatening uncertainties and potentially more threatening certainties, clinicians utilise skills drawn from differing fields to make the load of information, and the emotional impact more manageable. T… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

0
4
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
3

Relationship

1
2

Authors

Journals

citations
Cited by 3 publications
(4 citation statements)
references
References 32 publications
0
4
0
Order By: Relevance
“…Accordingly, carers and clinicians simultaneously perceive that obtaining a diagnosis is an important but initial stage of an ongoing therapeutic odyssey. 16 , 17 The push to develop and access new therapies aligns with the vision as set out by the International Rare Diseases Research Consortium, whose goal is to facilitate the approval of 1000 new therapies for rare diseases, the majority of which would focus on diseases without approved options, by 2027. 18 However, with over 95% of RNDs currently lacking a recourse to disease modification and many trials being conducted outside of Australia, the discrepancy between stakeholder expectations and realistic access to advanced therapies leaves a gap in which misinformation and uncertainty may predominate.…”
Section: Discussionmentioning
confidence: 99%
See 2 more Smart Citations
“…Accordingly, carers and clinicians simultaneously perceive that obtaining a diagnosis is an important but initial stage of an ongoing therapeutic odyssey. 16 , 17 The push to develop and access new therapies aligns with the vision as set out by the International Rare Diseases Research Consortium, whose goal is to facilitate the approval of 1000 new therapies for rare diseases, the majority of which would focus on diseases without approved options, by 2027. 18 However, with over 95% of RNDs currently lacking a recourse to disease modification and many trials being conducted outside of Australia, the discrepancy between stakeholder expectations and realistic access to advanced therapies leaves a gap in which misinformation and uncertainty may predominate.…”
Section: Discussionmentioning
confidence: 99%
“…Similarly, development of standardised resources that inform the therapeutic journey may enable the unique attributes and complexities of clinical trials in RNDs to be fully understood, empowering carers to partake in informed decision‐making, setting realistic therapeutic expectations, while maintaining hope. 17 Building on these findings, we are partnering with families to co‐design and co‐produce psychoeducational resources featuring their voices. Moving forward, the development of educational resources for young people is also essential.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…We have seen in the first two articles 1,2 in this three-part series that uncertainty and certainty around life-limiting, deeply distressing and relationship-impairing paediatric neurological disorders can provide formidable challenges to personal hopefulness for parents, families as well as the affected child. This hopelessness can consolidate into an active despair and bleed into the clinical team's capacity to help professionally and hope personally.…”
Section: A Credible and Meaningful Hopefulness In The Irreducibly Tragicmentioning
confidence: 99%